| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |